[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Agilon Health Inc (AGL)

Agilon Health Inc (AGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why agilon health (AGL) Shares Are Falling Today

Why agilon health (AGL) Shares Are Falling Today

AGL : 100.27 (-16.36%)
Kaskela Law Firm Announces Investigation of Agilon Health, Inc. (AGL) and Encourages Long-Term AGL Shareholders with Investment Losses to Contact the Firm

Investor litigation firm Kaskela Law announces that it is investigating Agilon Health, Inc. (NYSE: AGL) (“Agilon”) on behalf of the company’s long-term investors. ...

AGL : 100.27 (-16.36%)
3 Unpopular Stocks We’re Skeptical Of

3 Unpopular Stocks We’re Skeptical Of

AGL : 100.27 (-16.36%)
VTRS : 17.28 (+1.59%)
REYN : 25.21 (-2.96%)
agilon health Reports ACO REACH Model Results for 2024 Performance Year

In 2024, agilon REACH ACOs achieved $229 million in gross savings and 96% quality score Since joining the model in 2021, agilon REACH ACOs achieved $510...

AGL : 100.27 (-16.36%)
1 Momentum Stock on Our Buy List and 2 Facing Challenges

1 Momentum Stock on Our Buy List and 2 Facing Challenges

PRU : 117.84 (-0.85%)
WWD : 411.94 (+1.82%)
AGL : 100.27 (-16.36%)
agilon health Sets Date to Report Second Quarter 2026 Financial Results

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the second quarter 2026...

AGL : 100.27 (-16.36%)
3 Reasons AGL is Risky and 1 Stock to Buy Instead

3 Reasons AGL is Risky and 1 Stock to Buy Instead

AGL : 100.27 (-16.36%)
1 Small-Cap Stock on Our Watchlist and 2 We Question

1 Small-Cap Stock on Our Watchlist and 2 We Question

PLOW : 46.11 (-0.92%)
EFSC : 65.04 (-0.97%)
AGL : 100.27 (-16.36%)
3 Healthcare Stocks with Questionable Fundamentals

3 Healthcare Stocks with Questionable Fundamentals

SOLV : 77.24 (-0.52%)
AGL : 100.27 (-16.36%)
DHR : 192.50 (+7.46%)
3 Russell 2000 Stocks We’re Skeptical Of

3 Russell 2000 Stocks We’re Skeptical Of

AGL : 100.27 (-16.36%)
BANF : 114.92 (-0.38%)
ERII : 8.41 (-1.52%)

Barchart Exclusives

Investors Keep Buying the DRAM ETF Despite the Selloff. They Might Be Right About Memory Stocks.
Despite a recent selloff, investors continue pouring money into the DRAM ETF, betting that robust AI-driven demand will fuel another leg higher in memory chip stocks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.